VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 715 filers reported holding VANECK VECTORS ETF TR in Q4 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $14,216,111 | -33.1% | 528,295 | -25.2% | 0.02% | -44.7% |
Q2 2023 | $21,248,007 | +3.9% | 706,133 | +12.7% | 0.04% | 0.0% |
Q1 2023 | $20,454,635 | +10.0% | 626,813 | -3.4% | 0.04% | 0.0% |
Q4 2022 | $18,593,344 | +62.7% | 648,736 | +36.9% | 0.04% | +46.2% |
Q3 2022 | $11,426,000 | -38.4% | 473,740 | -29.9% | 0.03% | -36.6% |
Q2 2022 | $18,551,000 | -22.3% | 675,552 | -3.9% | 0.04% | -10.9% |
Q1 2022 | $23,867,000 | +22.5% | 702,698 | +15.2% | 0.05% | +24.3% |
Q4 2021 | $19,481,000 | +21.6% | 609,985 | +12.1% | 0.04% | +12.1% |
Q3 2021 | $16,024,000 | -15.8% | 544,047 | -2.9% | 0.03% | -19.5% |
Q2 2021 | $19,037,000 | +11.6% | 560,263 | +7.1% | 0.04% | 0.0% |
Q1 2021 | $17,055,000 | +6.6% | 523,280 | +17.8% | 0.04% | -4.7% |
Q4 2020 | $16,004,000 | -9.3% | 444,286 | -1.8% | 0.04% | -18.9% |
Q3 2020 | $17,646,000 | +4.2% | 452,496 | -2.0% | 0.05% | -7.0% |
Q2 2020 | $16,933,000 | +125.4% | 461,676 | +0.1% | 0.06% | +83.9% |
Q1 2020 | $7,511,000 | – | 461,163 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |